Weekly round up from Life Sciences Industry.
Shanghai-based medical AI startup Synyi announced that it has raised RMB 250M ($36.3M) in Series C funding led by Chinese tech giant Tencent. Founded in 2016, Synyi started with Natural Language Processing (NLP) capabilities in the Chinese language and focused on hospitals? demand for scientific research data, combining AI & HIT to create their first smart analytics platform.
Date: July 16, 2019
Source: DistilNFO
Sign up for DistilINFO e-Newsletters.
Apteryx Imaging Inc. Announces Closing of Acquisition by Planet DDS
UC Davis Health, AWS Launches Cloud Innovation Center for Health Equity
Why Acadia Healthcare Shares Went Crazy — Temporarily
Qiagen Fully Acquires Neumodx Molecular, Inc., Rounding Out Portfolio of PCR-Based Diagnostic Automation Systems
Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.
Wolters Kluwer Targets Health Equity with Best Care Everywhere
Verily Forms New Subsidiary Focused on Employer Stop-Loss Through Precision Risk
USC Norris launches study to increase diversity among clinical trial participants